See also this year's filing and all EDGAR filings for this company.
PDF Report 0001710072_2022_Edgewise_Therapeutics_Inc.pdf
Logs
Graph
Absolute values for 0001710072, Edgewise Therapeutics Inc
| xvar | xval | |
|---|---|---|
| 0 | AssetsCurrent | 283,773,000 |
| 1 | IntangibleAssetsNetIncludingGoodwill | 0 |
| 2 | PropertyPlantAndEquipmentNet | 912,000 |
| 3 | remainder_Assets | 548,000 |
| 4 | LiabilitiesCurrent | 10,521,000 |
| 5 | LiabilitiesNoncurrent | 329,000 |
| 6 | remainder_Liabilities | 0 |
| 7 | CostOfGoodsAndServicesSold | 0 |
| 8 | SellingGeneralAndAdministrativeExpense | 11,026,000 |
| 9 | ResearchAndDevelopmentExpense | 32,189,000 |
| 10 | remainder_Expenses | 0 |
| 11 | remainder_Revenues | 402,000 |
| 12 | remainder_NetIncome | 0 |
| 13 | remainder_ComprehensiveNetIncome | -514,000 |
| yvar | yval | |
|---|---|---|
| 0 | Assets | 285,233,000 |
| 1 | Liabilities | 10,850,000 |
| 2 | Expenses | 43,215,000 |
| 3 | Revenues | 402,000 |
| 4 | StockholdersEquity | 274,383,000 |
| 5 | NetIncome | -42,813,000 |
| 6 | ComprehensiveNetIncome | -43,070,000 |
| 7 | BaseVar | 170,107,000 |
| 8 | EconomicCapitalRatiobeforeLimitedLiability | 3.75 |
| 9 | EconomicCapitalRatio | 4.21 |
Edgar->Model Mapping
Feature Distribution
